International Bone and Mineral Society

Pieter Johannes Gaillard (1907–1992)

International Bone and Mineral Society (IBMS) is a professional, scientific society dedicated to the research and study of the bone, mineral metabolism, and related fields. The society aims to promote the advancement of knowledge in the bone and mineral area, facilitate the sharing of research findings among scientists and clinicians worldwide, and improve the care of patients with bone and mineral disorders.

History

The International Bone and Mineral Society was established to foster and integrate research in the fields of bone and mineral metabolism across disciplines and national boundaries. The society has grown to include members from a wide range of disciplines, including biology, medicine, nutrition, pharmacology, and epidemiology, reflecting the interdisciplinary nature of the field.

Mission

The mission of the IBMS is to advance the understanding of bone and mineral science to improve the treatment of patients with bone and mineral disorders. This is achieved through the promotion of research, facilitating collaboration among scientists and clinicians, and the dissemination of knowledge through its conferences, publications, and educational programs.

Activities

The IBMS organizes international conferences, workshops, and symposia, where researchers and clinicians can present their latest findings, share ideas, and establish collaborations. The society also publishes a scientific journal, which serves as a platform for the dissemination of cutting-edge research in the field of bone and mineral metabolism.

Membership

Membership in the IBMS is open to researchers, clinicians, and professionals involved in the study of bone and mineral metabolism. Members benefit from access to the society's publications, reduced registration fees for conferences, and opportunities for networking and professional development.

Impact

The work of the IBMS has contributed significantly to the understanding of bone and mineral metabolism and the development of new treatments for diseases such as osteoporosis, Paget's disease of bone, and other metabolic bone diseases. The society plays a crucial role in bringing together the global research community to address the challenges in this field.